Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Babies born Early Antibody Response to Men B vaccination (BEAR Men B)
2017-001487-38Phase 4Completed
- Sponsor
- St George's, University of London
- Start
- May 2018
- Countries
- 1
01
Overview
Phase 4, randomised trial of meningococcal group B vaccine in meningococcal disease (2 arms), sponsored by St George's, University of London. Primary endpoint: Primary: hSBA GMTs for 4CMenB antigens. Started May 2018; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-001487-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001487-38.